OncoSec Medical Inc Sustainability Reports
OncoSec Medical Incorporated is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system against advanced cancers. The company utilizes a proprietary electroporation delivery system to target and treat solid tumors.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 529900NA4JNULYG7UU40
FIGI: BBG001SCVQN3
3 reports from 2017 to 2019
